Evidence map›Paper›PMID 41531834›Full record

ArticleTransplantation direct2026

Major Histocompatibility Complex Class I Matching is Necessary but not Sufficient for Tolerance Induction to Vascularized Composite Allografts After Donor Hematopoietic Cell Transplantation.

Elin Manell, M Esad Gunes, Sarah Merl, Satyajit Patwardhan, Ishit Chauhan, Julie Hong, Bryan Chen, Philip Jordache, Ahmed Almesalmy, Dilrukshi Ekanayake-Alper and 10 more

Abstract read
In one paragraph

Article in Transplantation direct, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Elin ManellDepartment of Medicine, Columbia Center for Translational Immunology, Columbia University, New York, NY.ORCID https://orcid.org/0000-0002-4491-7609
M Esad GunesDepartment of Medicine, Columbia Center for Translational Immunology, Columbia University, New York, NY.ORCID https://orcid.org/0000-0002-7025-3826
Sarah MerlDepartment of Pathology and Cell Biology, Columbia University, New York, NY.ORCID https://orcid.org/0009-0000-5227-5047
Satyajit PatwardhanDepartment of Medicine, Columbia Center for Translational Immunology, Columbia University, New York, NY.ORCID https://orcid.org/0000-0002-6334-0788
Ishit ChauhanDepartment of Medicine, Columbia Center for Translational Immunology, Columbia University, New York, NY.ORCID https://orcid.org/0009-0000-4323-0410
Julie HongDepartment of Medicine, Columbia Center for Translational Immunology, Columbia University, New York, NY.ORCID https://orcid.org/0000-0002-2035-0660
Bryan ChenDepartment of Medicine, Columbia Center for Translational Immunology, Columbia University, New York, NY.
Philip JordacheDepartment of Medicine, Columbia Center for Translational Immunology, Columbia University, New York, NY.
Ahmed AlmesalmyDepartment of Medicine, Columbia Center for Translational Immunology, Columbia University, New York, NY.ORCID https://orcid.org/0009-0008-0631-5288
Dilrukshi Ekanayake-AlperDepartment of Medicine, Columbia Center for Translational Immunology, Columbia University, New York, NY.
Dominik HajosiDepartment of Medicine, Columbia Center for Translational Immunology, Columbia University, New York, NY.
Sameera HusainDepartment of Dermatology, Columbia University, New York, NY.
Cheng-Shie WuuDepartment of Radiation Oncology, Columbia University, New York, NY.
Matthew WrightDepartment of Surgery, Columbia University/New York-Presbyterian Hospital, New York, NY.
Jarrod BogueDepartment of Surgery, Columbia University/New York-Presbyterian Hospital, New York, NY.ORCID https://orcid.org/0000-0003-0031-6438
Christine RohdeDepartment of Surgery, Columbia University/New York-Presbyterian Hospital, New York, NY.ORCID https://orcid.org/0000-0001-9005-7753
Kumaran ShanmugarajahDepartment of Surgery, University of Chicago, Chicago, IL.ORCID https://orcid.org/0009-0005-3056-352X
Curtis L CetruloDepartment of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA.ORCID https://orcid.org/0000-0001-7080-3894
David H SachsDepartment of Medicine, Columbia Center for Translational Immunology, Columbia University, New York, NY.ORCID https://orcid.org/0000-0001-9588-8580
Joshua WeinerDepartment of Medicine, Columbia Center for Translational Immunology, Columbia University, New York, NY.ORCID https://orcid.org/0000-0003-3780-1875

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: We previously reported a porcine model of vascularized composite allograft (VCA) transplantation with concurrent hematopoietic cell transplantation (HCT). Tolerance developed when major histocompatibility complex (MHC) class I was matched in the absence of class II matching but not when class II was matched without class I matching. We investigated whether rejection resulted from a mismatch between class I and class II. Methods: Recipient pigs were either mismatched from donors by a single class I haplotype or matched by a single class II haplotype. They received CD3 immunotoxin and total-body irradiation followed by HCT and VCA transplantation from the same donor. Cyclosporine immunosuppression was discontinued after 45 d. Results: Pigs mismatched for only 1 MHC class I haplotype maintained peripheral chimerism and accepted the VCA graft, except for 1 animal that rejected the epidermis. Pigs matched for only 1 MHC class II haplotype lost bone marrow engraftment and rejected the VCA graft. Conclusions: When combined with our prior experiments, our results suggest that some degree of MHC class I matching is necessary for tolerance induction to HCT/VCA, but this is dependent on the degree of class II matching. Full class I matching reliably generates VCA tolerance, regardless of the degree of class II matching. VCA tolerance fails to develop reliably when MHC class I is fully mismatched, regardless of the degree of class II matching. When a single class I haplotype is matched, VCA tolerance depends on the degree of class II matching.

Identifiers

PMID41531834
PMCPMC12795049

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.